Investigators assessed the frequency of lupus flares in patients with kidney failure undergoing dialysis or with a kidney transplant.

Although systemic lupus erythematosus cannot be cured, there are a number of drugs available to help manage this chronic ...

Dry Eye Syndrome (DES) is increasingly prevalent due to digital screen usage and environmental factors, affecting various age ...

WELLESLEY HILLS, Mass., May 14, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical stage biotechnology company developing therapeutics for patients with immune-mediated diseases, ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Comprehensive overview of lupus in India, symptoms, treatment, and challenges faced in diagnosis and management.

Q1 2025 Earnings Conference Call May 9, 2025 10:00 AM ETCompany ParticipantsJustine Koenigsberg - Vice President ...

At univariable analysis, both anti-C1q antibodies and non-use of hydroxychloroquine predicted renal flares at baseline and 6 and 12 months. Proteinuria (24/h proteinuria and proteinuria 0.5 g/day or ...

As a novel calcineurin inhibitor with proven efficacy in improving renal outcomes, LUPKYNIS addresses a high unmet medical need. With increasing awareness, supportive guidelines, and potential ...

DelveInsight's "LUPKYNIS Market Size, Forecast, and Market Insight Report" highlights the details around LUPKYNIS, the first ...

CEO John Aballi highlighted several important developments, including the successful integration of new biomarkers into the AVISE CTD test. He noted that these biomarkers have driven a $90 incremental ...

Although we’re not exhibiting this year, we can’t wait to connect with customers and suppliers. Meet our ACM team at the Brisbane Truck Show 2025. Our sales team includes Robert Scott (over 30 years ...